Biochemical parameters statistical relevance between CAD and non-CAD
| CAD | nonCAD | All patients | Sample size | ANOVA | |
|---|---|---|---|---|---|
| Mean (StDev) | Mean (StDev) | Mean (StDev) | (CAD/non -CAD) | p | |
| Age | 64.72(±8.3) | 61.83(±9.4) | 63.68(±8.8) | 106/59 | 0.0428 |
| Statins (mg/day) | 31.42(±17.9) | 21.95(±17.7) | 28.03(±18.3) | 106/59 | 0.0013 |
| Glucose | 7.46(±3.3) | 6.57(±2.1) | 7.15(±2.8) | 103/58 | 0.0508 |
| Lp(a) | 40.21(±50.2) | 16.51(±15.2) | 32.19(±43.2) | 84/43 | 0.0031 |
| ApoB | 0.92(±0.3) | 0.9(±0.2) | 0.91(±0.3) | 101/57 | 0.7213 |
| ApoA1 | 1.23(±0.2) | 1.36(±0.3) | 1.28(±0.2) | 99/57 | 0.001 |
| HDL | 1.12(±0.3) | 1.28(±0.3) | 1.17(±0.3) | 103/53 | 0.0011 |
| LDL | 1.83(±0.9) | 1.89(±0.8) | 1.85(±0,9) | 99/56 | 0.7001 |
| Total Cholesterol | 3.7(±1.3) | 3.45(±0.8) | 3.7(±1.1) | 103/55 | 0.8718 |
| TG | 1.17(±0.7) | 1.18(±0.7) | 1.18(±0.7) | 97/56 | 0.9699 |
| ACT | 22.7(±16.8) | 22.29(±8.2) | 22.56(±14.3) | 104/58 | 0.8622 |
Association between QQ vs_ QR and non-CAD vs_ stenting
| non-CAD | Stenting | χ2 | OR (95% CI) | p | |
|---|---|---|---|---|---|
| 20 (E=14.75) | 17 (E=22.25) | 4.1432 | 0.461[0.216–0.589] | 0.0418 | |
| QR+RR | 39 (E=44.25) | 72 (E=66.75) |
Profile of the patient group in the study
| CAD | non-CAD | |
|---|---|---|
| Gender (Male) | 80 (72%) | 31(28%) |
| Gender (Female) | 26 (48%) | 28 (52%) |
| Nationality (Macedonian) | 87 (66%) | 45 (34%) |
| Nationality (Albanians) | 19 (58%) | 14 (42%) |
| Smoking | 31 (70%) | 13 (30%) |
| Stent | 36 (100%) | 0 (0%) |
| Restenosis | 46 (100%) | 0 (0%) |
| Diabetes | 36 (72%) | 14 (28%) |
| Q192R(QQ) | 22 (52%) | 20 (48%) |
| Q192R(QR) | 81 (67%) | 39 (33%) |
| Q192R(RR) | 2 (100%) | 0 (0%) |
Statistical relevance of the biochemical parameters between QQ and QR+RR
| QR | QR+RR | All patients | Sample size | ANOVA | ||
|---|---|---|---|---|---|---|
| Mean (StDev) | Mean (StDev) | Mean (StDev) | Mean (StDev) | QQ/QR/QR+RR | p | |
| Age | 62.73(±10.2) | 64.18(±8.2) | 64.2(±8.2) | 63.92(±8.2) | 45/120/122 | 0.2756 |
| Statins | 28.67(±19.7) | 28.29(±17.7) | 28 (±17.8) | 27.97(±18.2) | 45/120/122 | 0.9437 |
| Glucose | 7.71(±3.3) | 6.93(±2.6) | 6.95(±2.6) | 7.14(±2.8) | 41/117/120 | 0.1375 |
| Lp(a) | 32.81(±43) | 30.73(±41.2) | 31.98(±43.4) | 32.19(±43.2) | 32/92/95 | 0.9260 |
| ApoB | 0.9(±0.3) | 0.89(±0.3) | 0.9(±0.3) | 0.91(±0.3) | 40/115/118 | 0.2952 |
| ApoA1 | 1.3(±0.3) | 1.27(±0.2) | 1.27(±0.2) | 1.28(±0.2) | 40/113/116 | 0.5834 |
| HDL | 1.23(±0.3) | 1.16(±0.3) | 1.16(±0.3) | 1.17(±0.3) | 38/115/118 | 0.1731 |
| LDL | 2(±0.8) | 1.81(±0.9) | 1.8(±0.9) | 1.85(±0.9) | 40/112/115 | 0.2129 |
| Total Chol. | 3.97(±1) | 3.62(±1.1) | 3.62(±1.1) | 3.71(±1.1) | 41/114/117 | 0.0729 |
| TG | 1.2(±0.7) | 1.16(±0.7) | 1.17(±0.7) | 1.18(±0.7) | 39/112/114 | 0.7881 |
| ACT | 20.9(±8.1) | 23.1(±16) | 23.12(±15.9) | 22.56(±14.3) | 41/118/121 | 0.3934 |
Association between QQ vs_ QR and non-CAD vs_ CAD
| non-CAD | CAD | χ2 | OR (95% CI) | p | |
|---|---|---|---|---|---|
| 20 (E=15.02) | 22 (E=26.98) | 3.4508 | 0.511[0.25–0.595] | 0.0632 | |
| QR+RR | 39 (E=43.98) | 83 (E=79.02) |